Boswellia
Boswellia serrata
TL;DR
Boswellia extract standardised to boswellic acids reduces osteoarthritis pain and stiffness in randomised trials, with effects appearing within 5-7 days — unusually fast for a botanical. Best evidence is for knee osteoarthritis at 100-250 mg/day of enriched extract or 900-1,500 mg/day of standard extract.
Ideal For
- Knee osteoarthritis pain and stiffness
- People who cannot tolerate NSAIDs gastrically
- Those wanting a faster-acting alternative to glucosamine
- Adjunct in ulcerative colitis under supervision
Avoid If
- Pregnancy or breastfeeding
- Taking warfarin or other anticoagulants without monitoring
- Known resin or frankincense allergy
Frequently Asked Questions
Overview
Boswellia occupies an unusual position among joint supplements: it acts on a genuinely different inflammatory pathway from both NSAIDs and glucosamine, and it has randomised trials showing benefit within days rather than months. The resin from Boswellia serrata contains a family of pentacyclic triterpenes known as boswellic acids, of which acetyl-11-keto-beta-boswellic acid (AKBA) is the most pharmacologically active. Because AKBA typically makes up only 1-3% of unenriched resin, product standardisation matters more here than for almost any other botanical — enriched extracts such as 5-Loxin and Aflapin deliver 20-30% AKBA and are what the better trials used. Beyond osteoarthritis, boswellia has a smaller literature in ulcerative colitis, Crohn disease and asthma, all reflecting the same leukotriene-suppressing mechanism, though none of those indications has the trial depth of the joint work.
How It Works
- Inhibits 5-lipoxygenase, cutting leukotriene production
- Spares the COX pathway, so no NSAID-type gastric injury
- Inhibits leukocyte elastase, reducing connective tissue breakdown
- Suppresses NF-kB and downstream matrix metalloproteinases
Quick Facts
- Acts on the 5-LOX pathway, not COX
- Onset in osteoarthritis trials is often within 5-7 days
- AKBA content, not total resin, determines potency
- Does not carry NSAID gastric risk
Benefits & Outcomes
Joint Comfort
Boswellia serrata (AKBA-standardized) reduced OA pain and improved function in RCTs — a strong second botanical alongside curcumin.
Pain Relief
Boswellia shows promising osteoarthritis pain reduction in short trials, often paired with curcumin.
Supporting Research9 studies
Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study
Haroyan A, Mukuchyan V, Mkrtchyan N +5 more
In 201 adults aged 40-70 with knee osteoarthritis, 12 weeks of curcuminoid complex with turmeric volatile oil (500 mg three times daily) significantly reduced WOMAC pain and improved physical performance versus placebo; the curcumin plus boswellic acid combination produced larger improvements than curcumin alone.
Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis
Yu G, Xiang W, Zhang T +3 more
Boswellia significantly reduced pain and stiffness and improved joint function versus placebo in osteoarthritis, with benefits observed from about 4 weeks of treatment.
Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis
Liu X, Machado GC, Eyles JP +2 more
Of 20 supplements investigated in 69 eligible studies, 7 (collagen hydrolysate, passion fruit peel extract, Curcuma longa extract, Boswellia serrata extract, curcumin, pycnogenol and L-carnitine) demonstrated large (effect size >0.80) and clinically important effects for pain reduction at short term.
A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee
Vishal AA, et al
Aflapin is a safe, fast acting and effective alternative intervention in the management of OA.
Co-analgesic therapy for arthroscopic supraspinatus tendon repair pain using a dietary supplement containing Boswellia serrata and Curcuma longa: a prospective randomized placebo-controlled study
Merolla G
The dietary supplement alleviated short and partially mid-term pain, while long-term pain was unchanged.
A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee
Sengupta K, Alluri KV, Satish AR +1 more
5-Loxin Boswellia extract reduced knee pain and improved physical function versus placebo within 7 days, with reductions in synovial fluid matrix metalloproteinase-3.
The effect of turmeric-boswellia formulation (Rhuleave-K) in posture-related low back soreness and discomfort: a randomized double blinded placebo controlled trial
Gupta A, Agarwal A
Posture-related low back soreness and discomfort was significantly reduced by Rhuleave-K at 500 mg dose.
Efficacy evaluation of standardized Boswellia serrata extract (Aflapin) in osteoarthritis: A systematic review and sub-group meta-analysis study
Karlapudi V, et al.
Subgroup meta-analysis found the standardized Aflapin extract reduced WOMAC pain and stiffness scores significantly more than placebo in knee osteoarthritis.
Curcuminoids and Boswellia serrata extracts combination decreases tendinopathy symptoms
Henrotin Y, et al.
The combination of C. longa and B. serrata extracts improves symptoms in patients suffering of tendinopathy and shows a good safety. Although its effect will have to be confirmed in randomized controlled trials.
Safety Information
Potential Side Effects
Generally well tolerated. Mild gastrointestinal upset, nausea, acid reflux and diarrhoea occur in a minority. Skin rash is occasionally reported.
Contraindications
Avoid in pregnancy — traditional use as an emmenagogue raises theoretical uterine stimulation concerns. Use caution with anticoagulants given antiplatelet activity in vitro.
Drug Interactions
- Warfarin and other anticoagulants — theoretical additive bleeding risk
- NSAIDs — additive effect, not dangerous but may allow dose reduction
- CYP substrates — boswellic acids inhibit several CYP enzymes in vitro
Pregnancy & Breastfeeding
Pregnancy: likely_unsafe
Breastfeeding: insufficient_data
Dosage Guidelines
Dosage Used in Studies
100-1500 mg
Best Time to Take
Once or twice daily with a fat-containing meal
Best Form
AKBA-enriched extract (5-Loxin or Aflapin type) standardised to 20-30% AKBA
Bioavailability
Poor for AKBA in isolation; absorption improves markedly with dietary fat and with enriched or lecithin-formulated extracts.
Forms Compared
AKBA-enriched extract
Standard 65% boswellic acid extract
Whole resin
Food & Timing
Take with food containing fat — boswellic acid absorption increases substantially with a fatty meal.
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.